Table 1.
Demographic characteristics of study population in clinical trials 1 and 2 according to biogeographic group and study design.
n | Age | Weight (kg) | Height (m) | BMI (kg/m2) | |
---|---|---|---|---|---|
Total | 66 | 31.67 ± 8.47 | 77.14 ± 9.95 | 1.73 ± 0.06 | 25.62 ± 2.67 |
Biogeographic group: | |||||
Latino-American | 53 | 31.32 ± 8.11 | 77.00 ± 10.73 | 1.73 ± 0.07 | 25.60 ± 2.84 |
European | 13 | 33.08 ± 10.04 | 77.72 ± 6.10 | 1.74 ± 0.05 | 25.68 ± 1.93 |
Study design: | |||||
Fasting conditions | 33 | 29.55 ± 7.72 | 74.87 ± 8.50 | 1.74 ± 0.06 | 24.66 ± 2.44 |
Fed conditions | 33 | 33.79 ± 8.77 *† | 79.41 ± 9.95 | 1.73 ± 0.07 | 26.57 ± 2.57 *† |
Results are shown as mean ± standard deviation. *: p < 0.05 after univariate analysis. †: pmultivariate (MV) < 0.05.